経口抗がん剤治療を受けるがん患者における満たされていない情報ニーズと知識のギャップ
Anna K Moritz1, Wolfgang Fehrmann2, Markus K Schuler3,4
1Chair of Health Services Research, Institute of Medical Sociology, Health Services Research, and Rehabilitation Science (IMVR), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Exploratory research in clinical and social pharmacy
|December 22, 2025
まとめ
経口抗がん剤療法(OAT)を受けているがん患者は、特に服薬方法や副作用に関して、満たされていない情報ニーズや知識のギャップを抱えています。自宅での安全かつ効果的なOAT自己管理のためには、患者教育とサポートの最適化が不可欠です。
科学分野:
- 腫瘍学;患者の自己管理;健康リテラシー
背景:
- 経口抗がん剤療法(OAT)の使用が増加しており、患者の自己管理能力の向上が求められています。;安全かつ効果的な自宅でのOATには、適切な患者情報、カウンセリング、服薬リテラシーが不可欠です。;がん患者は、複雑な経口療法を自立して管理するために、特別なサポートを必要としています。
研究 の 目的:
- OATを受けているがん患者における満たされていない情報ニーズを特定すること。;OATの投与、相互作用、有害事象に関連する知識のギャップを特定すること。;OAT患者のための標的を絞った教育介入の開発に役立てること。
主な方法:
- OATを受けているがん患者への半構造化インタビューを用いた質的コンテンツ分析。;様々なクラスのOAT(化学療法、ホルモン療法、標的療法を含む)の使用経験についてインタビューを実施しました。;情報ニーズ、知識のギャップ、ニーズの認識に関連するテーマの特定に焦点を当てて分析しました。
主要な成果:
- OAT患者21人を対象としたインタビューにより、治療関連の情報ニーズと知識のギャップが著しく存在することが特定されました。;服薬方法の理解、潜在的な相互作用、有害事象の管理に関して、知識不足が認められました。;一部の患者は積極的に情報を避けていると報告しており、個別化されたコミュニケーション戦略の必要性が示唆されました。
結論:
- 特定された患者のニーズと知識のギャップは、OATに関する情報提供とカウンセリングの最適化の必要性を強調しています。;患者の自己管理能力の強化と外来カウンセリングサービスの改善は、治療の安全性と成功のために不可欠です。;本研究の結果は、OATを受けているがん患者のための専門職連携教育介入の開発の基礎を提供します。
関連する概念動画
Nursing Ethical Principles II
2.0K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.0K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


